Acute pulmonary vasodilatory properties of amlodipine in humans with pulmonary hypertension

Heart

Volumn 75, Issue 2, 1996, Pages 171-173

  Woodmansey, Paul A ^a,b   O'Toole, Lawrence ^a   Channer, Kevin S ^a   Morice, Alyn H ^a  

^a ROYAL HALLAMSHIRE HOSPITAL   (United Kingdom)

^b Department of Cardiology   (United Kingdom)

Author keywords

Acute pulmonary vasodilation; Amlodipine; Calcium antagonist; Pulmonary hypertension

Indexed keywords

AMLODIPINE; CALCIUM ANTAGONIST;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; FEMALE; HEMODYNAMICS; HUMAN; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; PULMONARY HYPERTENSION; THROMBOEMBOLISM; VASODILATATION;

EID: 0030026409     PISSN: 13556037     EISSN: None     Source Type: Journal    
DOI: 10.1136/hrt.75.2.171     Document Type: Article

References (14)

1. Wallcott G, Burchell HB, Brown AL Jr. Primary pulmonary hypertension. Am J Med 1970;49:70-9.
2. Hughes JD, Rubin LJ. Primary pulmonary hypertension. An analysis of 28 cases and a review of the literature. Medicine 1986;65:56-72.
3. Rich S, Dantzker DR, Ayres SM, et al. Primary pulmonary hypertension. A national prospective study. Ann Intern Med 1987;107:216-23.
4. Rich S, Kaufmann E, Levy P. The effect of high doses of calcium-channel blockers on survival in primary pulmonary hypertension. N Engl J Med 1992;327:76-81.
5. Rich S, Brundage BH, Levy PS. The effect of vasodilator therapy on the clinical outcome of patients with primary pulmonary hypertension. Circulation 1985;71:1191-6.
6. Murdoch D, Heel RC. Amlodipine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in cardiovascular disease. Drugs 1991;3: 478-505.
7. Osterloh I. The safety of amlodipine. Am Heart J 1989;118: 1114-20.
8. Neaton JD, Grimm RH, Prineas RJ, Stamler J, Grandits GA, Elmer PJ, et al. Treatment of mild hypertension study. JAMA 1993;270:713-24.
9. Woodmansey PA, Zhang F, Channer KS, Morice AH. The vasodilatory action of the calcium antagonist amlodipine on large and resistance pulmonary arteries from normoxic and chronically hypoxic rats. Clin Sci 1993;85:361-6.
10. Woodmansey PA, Zhang F, Channer KS, Morice AH. The effect of the calcium antagonist amlodipine on the two phases of hypoxic pulmonary vasoconstriction in rat large and small isolated pulmonary arteries. J Cardiovasc Pharmacol 1995;25:324-9.
11. Weir EK. Diagnosis and management of primary pulmonary hypertension. In: Wier EK, Reeves JT, eds. Pulmonary hypertension. New York: Futura Publishing Company, 1984:115-68.
12. Dantzker DR. Treating pulmonary hypertension. In: Weir EK, Archer SL, Reeves JT, eds. The diagnosis and treatment of pulmonary hypertension. New York: Futura Publishing Company, 1992:127-38.
13. Faulkner JK, McGibney D, Chasseaud LF, Perry JL, Taylor IW. The pharmacokinetics of amlodipine in healthy volunteers after single intravenous and oral doses and after 14 repeated oral doses given once daily. Br J Clin Pharmacol 1986;22:21-5.
14. Packer M, Medina N, Yushak M. Haemodynamic changes mimicking a vasodilator drug response in the absence of drug therapy after right heart catheterization in patients with chronic heart failure. Circulation 1985;71:761-6.